Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy

被引:3
作者
Ognibene, Dayane Teixeira [1 ]
Moss, Monique Bandeira [1 ]
Matsuura, Cristiane [1 ]
Brunini, Tatiana M. [1 ]
de Moura, Roberto Soares [1 ]
Mendes-Ribeiro, Antonio Claudio [1 ]
Resende, Angela de Castro [1 ]
机构
[1] Univ Estado Rio De Janeiro, Inst Biol, Dept Pharmacol, Rio De Janeiro, Brazil
关键词
blood platelets; cyclic GMP; nitric oxide; pregnancy; NITRIC-OXIDE SYNTHASE; BLOOD-PRESSURE; IN-VITRO; PREECLAMPSIA; AGGREGATION; ACTIVATION; ENDOTHELIUM; ARTERIES; CELLS; DEGRADATION;
D O I
10.1038/hr.2010.102
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Nitric oxide (NO) is a short-lived intercellular messenger that provides an efficient vascular regulatory mechanism to support homeostasis and prevent thrombosis. Endothelial dysfunction and reduced NO bioavailability have a central role in hypertension associated with pregnancy. The purpose of this study was to investigate the impact of pregnancy on the L-arginine-NO-cGMP pathway in platelets and its correlation to platelet function and blood pressure in normotensive rats and spontaneously hypertensive rats (SHRs). Platelets were obtained from blood on the 20th day of pregnancy from female SHRs (SHR-P) and normotensive controls (P) or age-matched nonpregnant rats (SHR-NP and NP). Intraplatelet NO synthase (NOS) activity was reduced in P compared to NP, despite unchanged L-arginine influx. The expression levels of endothelial NOS (eNOS) and inducible NOS (iNOS) were diminished during pregnancy in normotensive rats. Paradoxically, cyclic guanosine monophosphate (cGMP) levels were similar between NP and P, as were phosphodiesterase type 5 (PDE5) expression and platelet aggregation induced by adenosine diphosphate. In SHRs, L-arginine influx was reduced in SHR-P compared to SHR-NP. SHR-P exhibited impaired NOS activity and reduced iNOS expression compared with SHR-NP. Soluble guanylyl cyclase and PDE5 expression in platelets were lower in SHR-P than in SHR-NP, whereas no differences were noted between groups with respect to cGMP levels. However, increased levels of cGMP were observed in SHR-P compared to normotensive groups and platelet aggregability remained unaltered. In conclusion, these observations prompted the hypothesis that normal platelet aggregation in pregnant SHRs may be related to a reduction in PDE5 expression and consequently the maintenance of cGMP levels, independently of reduced platelet NO bioavailability. Hypertension Research (2010) 33, 899-904; doi: 10.1038/hr.2010.102; published online 17 June 2010
引用
收藏
页码:899 / 904
页数:6
相关论文
共 51 条
[21]   Maternal Adaptation in Pregnant Hypertensive Rats: Improvement of Vascular and Inflammatory Variables and Oxidative Damage in the Kidney [J].
Iacono, Anna ;
Bianco, Giuseppe ;
Raso, Giuseppina Mattace ;
Esposito, Emanuela ;
Bianca, Roberta d'Emmanuele di Villa ;
Sorrentino, Raffaella ;
Cuzzocrea, Salvatore ;
Calignano, Antonio ;
Autore, Giuseppina ;
Meli, Rosaria .
AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (07) :777-783
[22]   Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy [J].
Kakar, Puneet ;
Lip, Gregory Y. H. .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2007, 5 (03) :441-450
[23]   Reduced L-arginine level and decreased placental eNOS activity in preeclampsia [J].
Kim, YJ ;
Parkr, HS ;
Lee, HY ;
Ha, EH ;
Suh, SH ;
Oh, SK ;
Yoo, HS .
PLACENTA, 2006, 27 (4-5) :438-444
[24]   Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia [J].
Knock, GA ;
Poston, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (06) :1668-1674
[25]   PLATELET-VESSEL WALL INTERACTION - ROLE OF NITRIC-OXIDE, PROSTAGLANDINS AND ENDOTHELINS [J].
LUSCHER, TF .
BAILLIERES CLINICAL HAEMATOLOGY, 1993, 6 (03) :609-627
[26]  
Moncada S., 2006, V176, P213
[27]  
MONCADA S, 1993, NEW ENGL J MED, V329, P2002
[28]   Hypothalamic hypertensive factor - An inhibitor of nitric oxide synthase activity [J].
Morris, HR ;
Etienne, AT ;
Panico, M ;
Tippins, JR ;
Alaghband-Zadeh, J ;
Holland, SM ;
Mehdizadeh, S ;
de Belleroche, J ;
Das, I ;
Khan, NS ;
de Wardener, HE .
HYPERTENSION, 1997, 30 (06) :1493-1498
[29]   Diminished L-arginine bioavailability in hypertension [J].
Moss, MB ;
Brunini, TMC ;
De Moura, RS ;
Malagris, LEN ;
Roberts, NB ;
Ellory, JC ;
Mann, GE ;
Ribeiro, ACM .
CLINICAL SCIENCE, 2004, 107 (04) :391-397
[30]   Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling [J].
Mullershausen, F ;
Friebe, A ;
Feil, R ;
Thompson, WJ ;
Hofmann, F ;
Koesling, D .
JOURNAL OF CELL BIOLOGY, 2003, 160 (05) :719-727